Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling.
暂无分享,去创建一个
Antti Tanskanen | Raimond L Winslow | Deborah DiSilvestre | A. Tanskanen | D. Kass | R. Winslow | G. Tomaselli | F. Akar | D. Disilvestre | Gordon F Tomaselli | Andreas S Barth | Fadi G Akar | David A Kass | Yanli Tian | Zhong Gao | Yanli Tian | Zhong Gao
[1] R. Winslow,et al. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. , 1999, Circulation research.
[2] John Quackenbush,et al. Genesis: cluster analysis of microarray data , 2002, Bioinform..
[3] Robert H. Shoemaker,et al. Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides , 2006, Nucleic Acids Research.
[4] M. Le Cunff,et al. Transcriptomal analysis of failing and nonfailing human hearts. , 2003, Physiological genomics.
[5] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[6] Raimond L Winslow,et al. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. , 2004, Genomics.
[7] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Rosen,et al. T Wave Changes Persisting After Ventricular Pacing in Canine Heart Are Altered by 4‐Aminopyridine But Not by Lidocaine: Implications With Respect to Phenomenon of Cardiac ‘Memory’ , 1992, Circulation.
[9] J. Marín-García,et al. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. , 2001, Cardiovascular research.
[10] Vincenzo Lionetti,et al. Chronic Activation of Peroxisome Proliferator-Activated Receptor-α with Fenofibrate Prevents Alterations in Cardiac Metabolic Phenotype without Changing the Onset of Decompensation in Pacing-Induced Heart Failure , 2007, Journal of Pharmacology and Experimental Therapeutics.
[11] D. Lacroix,et al. The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy , 2007, Journal of cardiovascular pharmacology.
[12] Weike Mao,et al. Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. , 2004, American journal of physiology. Heart and circulatory physiology.
[13] David D Spragg,et al. Mechanisms Underlying Conduction Slowing and Arrhythmogenesis in Nonischemic Dilated Cardiomyopathy , 2004, Circulation research.
[14] D. Kass,et al. Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. , 2007, American journal of physiology. Heart and circulatory physiology.
[15] D. Kass,et al. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. , 1997, Journal of the American College of Cardiology.
[16] P. Boekstegers,et al. TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function. , 1997, Molecular and cellular biochemistry.
[17] Satoru Miyano,et al. Open source clustering software , 2004 .
[18] W. Tang,et al. Pathophysiology of congestive heart failure. , 2003, Reviews in cardiovascular medicine.
[19] W. Fiers,et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. , 1992, The Journal of biological chemistry.
[20] Ulrich Mansmann,et al. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. , 2006, Journal of the American College of Cardiology.
[21] G. Tomaselli,et al. Electrophysiological remodeling in hypertrophy and heart failure. , 1999, Cardiovascular research.
[22] Dinender K. Singla,et al. p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. , 2007, American journal of physiology. Heart and circulatory physiology.
[23] G. Moe,et al. Akt signaling pathway in pacing-induced heart failure , 2005, Molecular and Cellular Biochemistry.
[24] M. Dunn,et al. Protein changes observed in pacing‐induced heart failure using two‐dimensional electrophoresis , 1998, Electrophoresis.
[25] D. Kass,et al. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. , 1999, Circulation research.
[26] F. Recchia,et al. Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. , 2007, Physiological genomics.
[27] S. Vatner,et al. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. , 1999, Circulation.
[28] H. Hecht,et al. Electrophysiological Study of Human Heart Muscle , 1962, Circulation research.
[29] A. Nishiyama,et al. Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade , 2006, Journal of hypertension.
[30] R. Tunin,et al. Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure. , 2006, Journal of molecular and cellular cardiology.
[31] Joaquín Dopazo,et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments , 2006, Nucleic Acids Res..
[32] D. Kass,et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. , 1996, Circulation research.
[33] G. Tomaselli,et al. Regulation of Kv4.3 Current by KChIP2 Splice Variants: A Component of Native Cardiac Ito? , 2002, Circulation.